Skip to main content
. 2017 Mar 9;117(5):901–912. doi: 10.1007/s00421-017-3574-4

Table 4.

Blood PO2 and PCO2 during the CP experimental trials

Variables PLN ALN PLH ALH
Pre-supplement PCO2 (kPa) 5.3 ± 0.5 5.5 ± 0.5 5.1 ± 0.6 5.4 ± 0.6*
Pre-exercise PCO2 (kPa) 5.8 ± 0.3 5.7 ± 0.2 5.4 ± 0.4 5.7 ± 0.5
Post-exercise PCO2 (kPa) 5.2 ± 0.4 5.4 ± 0.5 5.1 ± 0.5 5.4 ± 0.5*
Pre-supplement PO2 (kPa) 9.0 ± 1.5 8.7 ± 1.3 8.3 ± 1.5 8.3 ± 2.0
Pre-exercise PO2 (kPa) 8.2 ± 1.3 8.6 ± 0.9 8.3 ± 1.7 8.5 ± 2.1
Post-exercise PO2 (kPa) 9.0 ± 3.7 10.0 ± 2.1 9.0 ± 2.0 7.6 ± 1.4

PLN represents the placebo normoxia condition, ALN represents the alkalosis normoxia condition, PLH represents the placebo hypoxia condition, ALH represents the alkalosis hypoxia condition

*Denote significant difference from placebo condition in the same environmental condition